S. Krause

发表

[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor

Patrick Dupont, John A Wagner, Koen Van Laere, 2007, Proceedings of the National Academy of Sciences.

In Vitro and in Vivo Properties of 3-tert-Butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA Receptor α5 Subtype-Selective Inverse Agonist

A. D. Rodrigues, K. Gingrich, G. Dawson, 2009, Journal of Pharmacology and Experimental Therapeutics.

In Vitro and in Vivo Properties of 3-tert-Butyl-7-(5-methylisoxazol-

A. D. Rodrigues, K. Gingrich, G. Dawson, 2009 .

Imaging in Research Using Nonhuman Primates

J. Gelovani, C. T. Winkelmann, P. McCracken, 2012 .

Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A–Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity

Yiyun Huang, J. Passchier, O. Barret, 2019, Molecular Imaging and Biology.

Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist.

T. Hayama, J. O'brien, S. Ozaki, 1999, The Journal of pharmacology and experimental therapeutics.

Comparison of the InVivo Distribution of Four Different Annexin A 5 Adducts in

E. Hostetler, C. Reutelingsperger, H. Mehmet, 2014 .

Comparison of the In Vivo Distribution of Four Different Annexin A5 Adducts in Rhesus Monkeys

E. Hostetler, C. Reutelingsperger, H. Mehmet, 2011, International journal of molecular imaging.

Neuropeptide-Y Y5 (NPY5) receptor: occupancy studies in Rhesus monkey using a novel NPY5 PET tracer

E. Hostetler, C. Ryan, S. Krause, 2006, NeuroImage.

Modeling of spatial metabolite distributions in the cardiac sarcomere.

Josep Roca, Marta Cascante, M. Cascante, 2007, Biophysical journal.

Potent, brain-penetrant, hydroisoindoline-based human neurokinin-1 receptor antagonists.

R. DeVita, R. Hargreaves, K. Tsao, 2009, Journal of medicinal chemistry.

Synthesis, characterization, and monkey PET studies of [18F]MK‐1312, a PET tracer for quantification of mGluR1 receptor occupancy by MK‐5435

Sandra M. Sanabria-Bohórquez, E. Hostetler, A. Joshi, 2011, Synapse.

Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: a head-to-head comparison with alendronate.

Donald S. Williams, L. Duong, B. Dardzinski, 2013, Bone.

Discovery of N-{(1S,2S)-2-(3-cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use.

H. Burns, R. Hargreaves, W. Hagmann, 2007, Journal of medicinal chemistry.

Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers

Christine Ryan, Kerry Riffel, Richard Hargreaves, 2005, Synapse.

Histamine H3 inverse agonist PET tracers labelled with carbon-11 or fluorine-18

S. Doran, L. Gantert, J. Renger, 2008, NeuroImage.

Evaluation of [18F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human

Hisashi Ohta, Koen Van Laere, Osamu Okamoto, 2013, NeuroImage.

In vitro characterization of [3H]MethoxyPyEP, an mGluR5 selective radioligand.

Shil Patel, Terence Hamill, Stephen M Krause, 2003, Life sciences.

Biodistribution and radiation dosimetry of [18F]F-PEB in nonhuman primates

Sandra M. Sanabria-Bohórquez, H. Burns, T. Hamill, 2008, Nuclear medicine communications.

Inverse agonist histamine H3 receptor PET tracers labelled with carbon‐11 or fluorine‐18

Christine Ryan, Richard Hargreaves, Shigeru Tokita, 2009, Synapse.